Skip to main content

Inspection visit

Health inspection

ANBERRY TRANSITIONAL CARECMS #5559016 citations on this visit
6 citations recorded

Inspector’s narrative

What the inspector wrote

This survey cited 6 deficiencies. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0554 Allow residents to self-administer drugs if determined clinically appropriate. Level of Harm - Minimal harm or potential for actual harm Based on observations, interviews, record review, and facility policy review, the facility failed to ensure a resident was assessed to determine if self-administration of medication was clinically appropriate for 1 (Resident #48) of 6 sampled residents reviewed for medication administration. Specifically, Resident #48 was found with two white pills in a small cup at bedside with no staff present without an assessment of the resident's ability to safely self-administer the medication. Residents Affected - Few Findings included: A review of a facility policy titled, Medications, Self-Administration, reviewed on 01/31/2022, revealed, It is the policy of this facility that an individual resident may self-administer specific medications if the IDT [interdisciplinary team] has determined that this practice is safe, and physician orders are obtained for self-administration of the specific medication(s). The policy specified, 2. If a resident voices desire to self-administer medications, the IDT is to assess the resident's cognitive, physical and visual ability to carry out this responsibility. 3. A licensed nurse is to complete the Self-Administration of Medication Assessment (UDA) [user defined assessment]. The resident is to be asked to read and understand the directions on the pharmacy label, and to administer his/her medications in the presence of a licensed nurse to demonstrate the ability to take the medication according to the safe practice and facility policy. 4. The self-administration assessment and any other information is to be reviewed by the resident's physician and IDT for final determination of the resident's ability to self-administer medications. The policy indicated, The resident may not begin self-administration of medications prior to the approval of the physician and IDT. A review of Resident #48's admission Record revealed the facility admitted the resident on 09/29/2023 with diagnoses that included end stage renal disease and dependence on renal dialysis. A review of an admission Minimum Data Set (MDS), with an Assessment Reference Date (ARD) of 10/04/2023, revealed Resident #48 had a Brief Interview for Mental Status (BIMS) score of 15, indicating the resident was cognitively intact. Per the MDS, Resident #48 received dialysis while residing in the facility. A review of Resident #48's care plan revised on 10/01/2023, t indicated the resident needed hemodialysis related to renal failure. A review of Resident #48's Order Summary Report, that listed active orders as of 10/30/2023, revealed an order dated 09/29/2023, for sevelamer carbonate (a medication used to lower high blood phosphorus levels in patients on dialysis) 800 milligrams (mg), two tablets by mouth before meals for hypocalcemia. There was no physician's order for Resident #48 to self-administer their medications. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 11 Event ID: 555901 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555901 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Anberry Transitional Care 1000 West Yosemite Avenue Merced, CA 95341 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0554 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few A review of Resident #48's Scheduling Details dated 09/29/2023, for the sevelamer carbonate 800 mg indicated the medication should be administered by a clinician. The options for Supervised Self-Administration and Unsupervised Self-Administration were not selected. In a concurrent observation and interview on 10/30/2023 at 11:37 AM, the surveyor noted two white pills in a small cup on Resident #48's bedside table while no staff was present in the resident's room. Resident #48 stated the two white pills in the small cup were phosphorus binders they took when they ate their meals. Resident #48 said they did not eat breakfast that morning, so they asked the nurse to leave the pills, and the resident planned to take one pill halfway through the next meal and the other after eating. Resident #48 further stated the facility staff had not spoken with the resident about self-administering the phosphate binder, but the nurses stood there while the resident took the rest of their medications. During an interview on 10/31/2023 at 1:26 PM, Licensed Vocational Nurse (LVN) #2 stated Resident #48 took the sevelamer carbonate when they ate and requested the nursing staff to leave the pills at bedside, so they had them available when they chose to eat. LVN #2 further stated Resident #48 had no swallowing difficulties and took this medication on their own at home. LVN #2 said Resident #48 sometimes did not eat their breakfast, so they did not take their sevelamer carbonate. LVN #2 said when this happened, the resident did not always let nursing staff know. During an interview on 11/02/2023 at 2:41 PM, the Director of Nursing (DON) stated if a resident wanted to self-administer medications, the facility must first assess the resident to determine if they were able, then the staff would obtain a physician's order. The DON said this process was important to ensure the resident could safely self-administer the medication. The DON said a self-administration assessment for Resident #48 to self-administer their sevelamer carbonate was not conducted until 10/31/2023. During an interview on 11/02/2023 at 2:51 PM, the Administrator stated he expected the nursing staff to follow the facility's procedure for medication self-administration. The Administrator said an assessment must be completed, it must be care planned, and there should be a physician's order in place for residents to self-administer medications. Per the Administrator, Resident #48's medication self-administration assessment was completed after they found out the resident took their medications on their own. The Administrator further stated it was important to follow the facility's medication self-administration procedure for resident safety. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555901 If continuation sheet Page 2 of 11 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555901 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Anberry Transitional Care 1000 West Yosemite Avenue Merced, CA 95341 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0645 PASARR screening for Mental disorders or Intellectual Disabilities Level of Harm - Minimal harm or potential for actual harm Based on interviews, record review, facility document review, and facility policy review, the facility failed to ensure a Level II evaluation was completed after a positive Level I Preadmission Screening and Resident Review (PASARR) for 1 (Resident #65) of 1 sampled resident reviewed for PASARRs. Residents Affected - Few Findings included: Review of guidance from the California Department of Health Care Services (DHCS), dated 08/09/2023, indicated, Purpose: The PASRR [Preadmission Screening and Resident Review] Information Notice (IN) clarifies the Hospitals' and SNFs' [skilled nursing facilities'] responsibilities to provide MCPs [Medi-Cal Managed Care Plans, health care for people with low or no income] confirmation that a PASRR Level I Screening was completed and to provide completed PASRR documentation for cases that advance to a Level II Evaluation with SNF referrals for prior authorization. Further review of the guidance indicated, PASRR documentation is no longer required to be sent to the MCP when a Level I Screening is negative for SMI [serious mental illness] and/or ID/DD/RC [intellectual disability/developmental disability/related condition]. It is only required when a Level I Screening is positive for SMI and/or ID/DD/RC and the case advances to a Level II Evaluation. Under this scenario, the MCP's approval of the prior authorization request will be pending until PASRR documentation is received. Once the PASRR process is completed, Hospitals and SNFs must provide the resulting Level II Evaluation letter to the MCP within three calendar days of issuance to obtain approval of the prior authorization request for SNF placement. A review of Resident #65's admission Record indicated the facility admitted the resident on 10/10/2023 with diagnoses that included bipolar disorder. Review of an admission Minimum Data Set (MDS), with an Assessment Reference Date (ARD) of 10/16/2023, revealed Resident #65 had a Brief Interview for Mental Status (BIMS) score of 15, which indicated the resident was cognitively intact. Review of Resident #65's care plan with an initiation date of 10/13/2023, revealed the resident had a mental health history that included bipolar disorder. A review of a letter from DHCS dated 10/10/2023 and sent to Resident #65 related to their positive Level I (PASARR) screening, indicated the facility would be contacted within two to four days to set up an appointment for an evaluator to conduct a Level II mental health evaluation. The letter also indicated that once the Level II mental health evaluation was completed, the resident would receive a report that provided recommendations for specialized services. The letter indicated a copy of the letter was also sent to the facility. A review of Resident #65's medical record, revealed no evidence of a Level II mental health evaluation. During an interview on 10/31/2023 at 11:28 AM, the Administrator said the facility received Resident #65's positive Level I PASARR when the facility admitted the resident, but the facility failed to note that the resident needed a Level II evaluation within two to four days of their positive Level I. The Administrator stated that it was the MDS Coordinator's responsibility to review a positive Level I PASARR upon admission and the MDS Coordinator should have noted the request to have a Level II evaluation. (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555901 If continuation sheet Page 3 of 11 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555901 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Anberry Transitional Care 1000 West Yosemite Avenue Merced, CA 95341 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0645 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few During an interview on 11/02/2023 at 10:31 AM, MDS Coordinator #6 stated that when the facility received a positive Level I PASARR, it was the MDS Coordinator's responsibility to ensure that a Level II evaluation was conducted in a timely manner. She said she was not working when the facility admitted Resident #65, so MDS Coordinator #7 would have reviewed the resident's Level I PASARR. She stated the positive Level I PASARR should have been caught and addressed when Resident #65 was first admitted so the resident subsequently received all the mental health services the resident needed for their mental illness. During an interview on 11/02/2023 at 10:41 AM, MDS Coordinator #7 stated that when the facility received Resident #65's positive Level I PASARR, she should have reached out to the transferring facility for information regarding the resident's mental illness and psychoactive medications so a Level II evaluation could be scheduled. MDS Coordinator #7 stated the importance of getting the Level II evaluation was to ensure the resident received necessary care and services for their mental illness. She said that she did not know why the Level II evaluation was missed for Resident #65. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555901 If continuation sheet Page 4 of 11 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555901 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Anberry Transitional Care 1000 West Yosemite Avenue Merced, CA 95341 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684 Provide appropriate treatment and care according to orders, resident’s preferences and goals. Level of Harm - Minimal harm or potential for actual harm Based on interviews, record review, and policy review, the facility failed to ensure staff monitored the skin as ordered by the physician for 1 (Resident #36) of 2 sampled residents reviewed for skin issues. Residents Affected - Few Findings included: Review of a facility policy titled, Skin Assessments, dated 07/18/2023, revealed Purpose: To ensure that every resident admitted to and residing at the facility has their skin checked on a routine basis for any conditions that require medical intervention. If skin breakdown occurs, a resident is to receive the appropriate treatment per physician's order. Review of Resident #36's admission Record revealed the facility readmitted the resident on 10/06/2023 with diagnoses that included fracture of neck of the left femur (hip area) and age-related osteoporosis with a current pathological fracture. Review of Resident #36's admission Minimum Date Set (MDS), with an Assessment Reference Date (ARD) dated 10/12/2023, revealed the resident had a Brief Interview for Mental Status (BIMS) of 11, which indicated the resident had moderate cognitive impairment. The MDS revealed the resident surgical wound(s) and received surgical wound care. Review of Resident #36's care plan dated 10/10/2023, revealed the resident had skin impairment as evidenced by a surgical site. The facility developed interventions that directed staff to monitor the skin each shift and report any changes to the physician and to provide treatment per the physician's order. Review of Resident #36's Order Summary Report which included active order as of 10/31/2023, revealed an ordered dated 10/06/2023, to monitor surgical site to the left hip each shift for signs and symptoms of infection and notify medical doctor. The resident also had a physician's order dated 10/07/2023, to monitor the surgical site to the resident's back each shift for signs and symptoms of infection and notify the medical doctor. Review of Resident #36's Treatment Administration Record [TAR] for October 2023, revealed staff documented the surgical site to the resident's back and left hip were monitored three times daily from 10/07/2023 to 10/31/2023. The TAR revealed, Licensed Vocational Nurse (LVN) #5 documented she monitored each of the resident's surgical sites on the evening shift on 10/29/2023 and 10/30/2023. Per the TAR, LVN #3 documented she monitored each of the resident's surgical sites each day shift from 10/25/2023 to 10/28/2023. Review of Resident #36's Skin Assessment dated 10/22/2023, revealed the surgical incision to the resident's lower back was scabbed and healing well. A review of the Skin Assessment, dated 10/25/2023, revealed the wound care physician examined the resident and noted there were no signs/symptoms of infection to the resident's left hip surgical site. During an interview on 10/30/2023 at 1:56 PM, Resident #36 stated they had surgical incisions. The resident stated the site to their left hip had not healed and no one at the facility had looked at their surgical sites. (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555901 If continuation sheet Page 5 of 11 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555901 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Anberry Transitional Care 1000 West Yosemite Avenue Merced, CA 95341 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few During an interview on 11/01/2023 at 12:08 PM, LVN #3 stated she had not looked at Resident #36's surgical site to their back or hip. LVN #3 stated Resident #36 was at the facility after a fracture, and the facility staff were to monitor the resident for signs and symptoms of an infection. LVN #3 stated she did not know where the resident's surgical sites were located and had not visualized the surgical sites. LVN #3 stated she had signed off on the TAR, indicating she completed monitoring of the resident's surgical sites, even though she had not seen or monitored the surgical sites. LVN #3 stated not following orders could lead to infection and complications. During an interview on 11/01/2023 at 1:53 PM, LVN #5 stated Resident #36 had a surgical site to their back only and she was not aware of any other surgical sites to the resident had. LVN #5 stated she should not have documented that monitoring of both surgical sites was completed. During an interview on 11/01/2023 at 2:38 PM, the Medical Doctor (MD) stated when there was an order to monitor incision sites each shift, he expected the nursing staff to monitor and look for signs of warmth, cellulitis, redness, and pain of the site. The MD also stated he expected the nurses to visually inspect the sites. In an interview on 11/02/2023 at 2:56 PM, the Director of Nursing (DON) stated the nursing staff should have completed daily skin monitoring of the surgical sites for Resident #36. Per the DON, the nursing staff should not document completion on the TAR if they had not completed the skin monitoring. During an interview on 11/02/2023 at 3:26 PM, the Administrator stated staff should not document completion of a skin assessment if the staff had not completed the assessment. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555901 If continuation sheet Page 6 of 11 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555901 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Anberry Transitional Care 1000 West Yosemite Avenue Merced, CA 95341 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695 Provide safe and appropriate respiratory care for a resident when needed. Level of Harm - Minimal harm or potential for actual harm Based on observations, interviews, record review, and policy reviews, the facility failed to ensure a bi-level positive airway pressure (BiPAP) mask and an updraft nebulizer mask were stored in a bag when they were not in use for 1 (Resident #58) of 2 sampled residents reviewed for respiratory care. Residents Affected - Few Findings included: Review of a facility policy titled, CPAP [continuous positive airway pressure] and BiPAP Use, revised on 01/31/2022, revealed, 11. Nursing staff is to ensure that the CPAP/BiPAP is kept clean at all times, and that the mask is cleaned according to the manufacturer's recommendations prior to each use. Review of a facility policy titled, Nebulizer Treatments, revised on 01/31/2022, revealed, 4. Remove nebulizer from plastic bag. Connect tubing to oxygen source and fill the nebulizer with prescribed medication. a. Nebulizer tubing and storage bags are to be changed weekly, on Sundays, and dated when changed. A review of Resident #58's admission Record indicated the facility readmitted the resident on 09/27/2023 with diagnoses that included acute and chronic respiratory failure with hypoxia, obstructive sleep apnea (OSA), chronic obstructive pulmonary disease (COPD), and dependence on supplemental oxygen. A review of Resident #58's admission Minimum Data Set (MDS), with an Assessment Reference Date (ARD) of 10/02/2023, revealed Resident #58 had a Brief Interview of Mental Status (BIMS) score of 15, indicating the resident was cognitively intact. The MDS revealed the resident received oxygen therapy and a non-invasive mechanical ventilator. Review of Resident #58's care plan with an initiation date of 10/04/2023, indicated the resident had shortness of breath (SOB) related to emphysema/COPD, OSA, and chronic respiratory failure. Review of Resident #58's Order Summary Report indicated an order dated 10/01/2023, for BiPAP 14/5 with oxygen (O2) every 12 hours as needed. The Order Summary Report revealed an order dated 10/23/2023, for albuterol sulfate inhalation nebulization solution every four hours as needed for SOB or wheezing and ipratropium-albuterol solution every six hours as needed for SOB or wheezing for 30 days. In an observation on 10/30/2023 at 10:38 AM, Resident #58's BiPAP mask and updraft nebulizer mask were noted lying on top of the resident's bed side table. The masks were not in bags or covered. Resident #58 said the nurses put their BiPAP mask on and took it off. The resident said the last time the BiPap mask was used was on 10/29/2023. Resident #58 also stated they received an updraft nebulizer treatment earlier this morning (10/30/2023). In an observation on 10/31/2023 at 7:23 AM, the surveyor noted Resident #58's BiPAP and updraft nebulizer mask were lying on top of the resident's bed side table and were not covered or in bags. During an observation on 11/01/2023 at 7:56 AM, the surveyor noted Resident #58's BiPAP mask was lying on top of the bed side table uncovered and not in a bag. Resident #58 said they did not wear the (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555901 If continuation sheet Page 7 of 11 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555901 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Anberry Transitional Care 1000 West Yosemite Avenue Merced, CA 95341 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695 BiPAP last night and it had been on top of the bed side table since the morning before. Level of Harm - Minimal harm or potential for actual harm During an interview on 11/01/2023 at 7:58 AM, Licensed Vocational Nurse (LVN) #3 said BiPAP and updraft nebulizer masks were to be kept in bags in residents' rooms when they were not in use. Residents Affected - Few During a telephone interview on 11/01/2023 at 2:39 PM, LVN #8 stated the normal process after administering a resident's updraft nebulizer treatment or when the staff took off a resident's BiPAP mask was to put the masks away; specifically, put them in bags. She indicated she gave Resident #58's updraft nebulizer treatment at 6:00 AM on 10/30/2023 and on 10/31/2023. She also indicated she did not know why she did not put the mask in a bag after she administered the resident their updraft nebulizer treatment but should have. LVN #8 said she had removed Resident #58's BiPAP mask several times lately and should have placed it in a bag when it was not in use. During an interview on 11/02/2023 at 7:05 AM, LVN #9 said BiPAP masks and updraft nebulizer masks were supposed to be stored in bags when they were not in use. She confirmed that she took off Resident #58's BiPAP mask Monday morning (10/30/2023) and had also given the resident their 6:00 AM updraft nebulizer treatment. She indicated she should have placed them in bags to prevent the spread of infection. During an interview on 11/02/2023 at 2:48 PM, the Director of Nursing indicated she expected BiPAP and updraft nebulizer masks to be placed in bags when they were not in use to prevent the spread of infection and prevent the risk of a respiratory infection. During an interview on 11/02/2023 at 3:19 PM, the Administrator stated that his expectation was to have the resident's BiPAP mask and updraft nebulizer mask placed in bags or covered when they were not in use to prevent the spread of infection. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555901 If continuation sheet Page 8 of 11 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555901 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Anberry Transitional Care 1000 West Yosemite Avenue Merced, CA 95341 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited. Based on interviews, record review, and policy review, the facility failed to ensure a resident's medication regimen was free from unnecessary medications for 1 (Resident #17) of 5 sampled residents reviewed for unnecessary medications. Specifically, Resident #17 had an order for lorazepam 0.5 milligrams (mg), one tablet by mouth every six hours as needed (PRN) for anxiety and agitation started on 06/15/2023 with no specified duration (stop date). Findings included: A review of a facility policy titled, Medications, Psychotherapeutic Drugs, reviewed on 01/31/2022, revealed, Purpose: To provide a therapeutic environment using only those medications with a therapeutic value to individual residents. The use of unnecessary drugs is to be avoided whenever possible. Policy: It is the policy of this facility that psychotherapeutic drugs will not be administered for purposes of discipline or convenience, and if required is to be used to treat the resident's medical symptoms. Each resident's drug regimen is to be free from unnecessary drugs. The section of the policy titled, Psychotherapeutic Drug Management specified, 3. Physician's orders for the psychotherapeutic medications must specify a f. Stop Date or Duration. A review of Resident #17's admission Record revealed the facility admitted the resident on 05/17/2022 with diagnoses that included type 2 diabetes mellitus and chronic kidney disease. Per the admission Record, on 06/14/2023, the resident received a diagnosis of anxiety disorder. A review of a quarterly Minimum Data Set (MDS), with an Assessment Reference Date (ARD) of 09/14/2023, revealed Resident #17 had a Brief Interview for Mental Status (BIMS) score of 13, indicating the resident was cognitively intact. Per the MDS, Resident #17 received hospice services while a resident of the facility and did not receive antianxiety medication during the seven-day assessment period. A review of Resident #17's care plan initiated on 06/20/2023, indicated the resident received antianxiety medication for an anxiety diagnosis manifested by agitation. A review of Resident #17's Order Summary Report, which listed active orders as of 11/02/2023, revealed an order dated 06/15/2023, for lorazepam 0.5 mg, one tablet by mouth every six hours PRN for anxiety and agitation. The order did not specify the duration of use (stop date). A review of a Note to Attending Physician/Prescriber, signed by a consultant pharmacist and dated 09/30/2023, revealed the following information regarding the pharmacist's review of Resident #17's PRN lorazepam order, patient is currently on PRN Lorazepam (Ativan) with the following diagnosis: anxiety. Please evaluate current diagnosis, behaviors and usage patterns and evaluate continued need. PRN psychotropic orders cannot exceed 14 days with the exception that the prescriber documents their rationale in the resident's medical record and indicate the duration for the PRN order. The handwritten physician/prescribed response indicated the medication was started when the resident was placed in hospice care on 06/14/2023 and there would be no changes in the medication at this time. During an interview on 11/01/2023 at 2:37 PM, the Medical Director stated he did not like using PRN antianxiety medications but received quite a bit of negative push back from the nurses and family (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555901 If continuation sheet Page 9 of 11 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555901 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Anberry Transitional Care 1000 West Yosemite Avenue Merced, CA 95341 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758 members who wanted the PRN medications available, so he just left the orders in place. Level of Harm - Minimal harm or potential for actual harm During an interview on 11/01/2023 at 3:56 PM, the Pharmacist stated PRN antianxiety medications should have a stop date included in the order and the use should be re-evaluated after 14 days. The Pharmacist further stated she notified facilities and physicians that there was no exception on PRN antianxiety use for hospice residents and that the orders still needed to have a stop date. Residents Affected - Few During an interview on 11/02/2023 at 2:41 PM, the Director of Nursing stated the facility tried to keep PRN antianxiety medications active for only 14 days but if the physician felt it appropriate for a hospice resident, they kept the PRN order in place. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555901 If continuation sheet Page 10 of 11 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555901 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Anberry Transitional Care 1000 West Yosemite Avenue Merced, CA 95341 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Many Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs. Based on observations, interviews, and policy review, the facility failed to ensure drugs and biologicals were stored in locked compartments and not left unlocked while they were unattended by authorized staff. This deficient practice was observed for 2 of 2 treatment carts in the facility and had the potential to affect all residents who resided on the 200 and 300 halls. Findings included: Review of a facility policy titled, Medications Storage, with a review date of 01/31/2022, revealed, It is the policy of this facility that all medications, drugs and biologicals are to be stored in a safe, secure and orderly manner, at a temperature as directed by the manufacturer, and accessible to only licensed nurses and the pharmacist in accordance with federal and state regulations. During an observation on 10/31/2023 at 7:21 AM, the treatment cart on the 300 Hall was observed unlocked and unattended. The contents of the treatment cart included tubes of lidocaine ointment (an aesthetic used to prevent and treat pain from some procedures, minor burns, scrapes, and insect bites), clotrimazole betamethasone cream (a combination medication used to treat a variety of inflamed fungal skin infections), permethrin cream (a medication used to treat scabies), and triamcinolone cream (a medication used to treat a variety of skin conditions). During an observation of the 200 Hall on 11/01/2023 at 12:06 PM, the surveyor noted the key was in left in the lock of the treatment cart and the treatment cart was unlocked and unattended. Licensed Vocational Nurse (LVN) #3 stated she accidentally left the key in the treatment cart lock and forgot to lock the cart. During an observation on 11/02/2023 at 1:08 PM, the treatment cart on the 200 Hall was unlocked and unattended. The contents of the treatment cart included antifungal cream and antifungal powder. In an interview on 11/02/2023 at 1:13 PM, LVN #3 stated the last person who accessed the 200 Hall treatment cart was LVN #12. During an interview on 11/02/2023 at 2:01 PM, LVN #12 confirmed she left the treatment cart unlocked and unattended and stated she thought she locked the cart. During an interview on 11/02/2023 3:56 PM, the Administrator stated it was his expectation that medication and treatment carts be locked when not in the line of sight of staff, and the keys be removed from the carts. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555901 If continuation sheet Page 11 of 11

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

6 citations recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0554GeneralS&S Dpotential for harm

    F554 - The right to self-administer medications if the interdisciplinary team, as

    Allow residents to self-administer drugs if determined clinically appropriate.

  • 0645GeneralS&S Dpotential for harm

    F645 - Preadmission Screening for individuals with a mental disorder and individuals

    PASARR screening for Mental disorders or Intellectual Disabilities

  • 0758GeneralS&S Dpotential for harm

    F758 - Medication Errors

    Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited.

  • 0761GeneralS&S Fpotential for harm

    F761 - Labeling of Drugs and Biologicals

    Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs.

  • 0684GeneralS&S Dpotential for harm

    F684 - Quality of care

    Provide appropriate treatment and care according to orders, resident’s preferences and goals.

  • 0695GeneralS&S Dpotential for harm

    F695 - Respiratory care, including tracheostomy care and tracheal suctioning

    Provide safe and appropriate respiratory care for a resident when needed.

FAQ · About this visit

Common questions about this visit

What happened during the November 2, 2023 survey of ANBERRY TRANSITIONAL CARE?

This was a inspection survey of ANBERRY TRANSITIONAL CARE on November 2, 2023. The surveyor cited 6 deficiencies, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at ANBERRY TRANSITIONAL CARE on November 2, 2023?

Yes, 6 deficiencies were cited, each with a CMS Scope and Severity grade. The first was: "Allow residents to self-administer drugs if determined clinically appropriate."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.